Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NIH 5OTHER 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Central Nervous System Neoplasms 11Breast Neoplasms 6Squamous Cell Carcinoma of Head and Neck 4Sarcoma 4Ovarian Neoplasms 3Lung Neoplasms 3Head and Neck Neoplasms 3Gliosarcoma 3Glioblastoma 3Endometrial Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Brain Neoplasms 3Astrocytoma 3Uterine Cervical Neoplasms 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Neuroblastoma 2Kidney Neoplasms 2Fallopian Tube Neoplasms 2Carcinoma, Intraductal, Noninfiltrating 2Breast Carcinoma In Situ 2Vomiting 1Urinary Bladder Neoplasms 1Tongue Neoplasms 1Teratoma 1Stomach Neoplasms 1Spinal Cord Neoplasms 1Solitary Fibrous Tumor, Pleural 1Sarcoma, Synovial 1Sarcoma, Endometrial Stromal 1

Interventions

Gemcitabine 3Carboplatin 3cabozantinib 2Magnetic Resonance Spectroscopy 2Interferon-alpha 2Granulocyte Colony-Stimulating Factor 2Gene Expression Profiling 2Filgrastim 2Etoposide 2Doxorubicin 2Cyclophosphamide 2tumor necrosis factor-alpha, CNGRC fusion protein, human 1siltuximab 1pembrolizumab 1peginterferon alfa-2b 1pegfilgrastim 1pazopanib 1lenvatinib 1fludarabine 1aldesleukin 1Vincristine 1Thrombopoietin 1Taxes 1Surgical Procedures, Operative 1Sunitinib 1Standard of Care 1Specimen Handling 1Radiotherapy 1Radiosurgery 1Radiation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Carcinoma, Renal Cell × Chemotherapy, Adjuvant × Clear all
NCT00053807 2012-09-24

Interleukin-2, Interferon Alfa, and Fluorouracil Compared With Observation in Treating Patients Who Have Undergone Surgery for Kidney Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Completed
96 enrolled
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡